FibroGen (FGEN) PT Lowered to $28 at Goldman Sachs

May 11, 2021 5:55 AM EDT
Get Alerts FGEN Hot Sheet
Price: $26.06 +3.62%

Rating Summary:
    5 Buy, 8 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 12 | Down: 7 | New: 31
Trade Now! 
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on FibroGen (NASDAQ: FGEN) to $28.00 (from $32.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change